Australian Broker Call *Extra* Edition – Apr 27, 2025

This story features ALCIDION GROUP LIMITED, and other companies. For more info SHARE ANALYSIS: ALC

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

ALC   ALD   BOQ   CKF (2)   CVV   DHG   DYL   FEX   ILU   KAR (2)   MYX   NAN   NEC   NWS   PRN   QBE   REA   RIO   SEK   SHV   STN   THL   TLX  

ALC    ALCIDION GROUP LIMITED

Healthcare services – Overnight Price: $0.08

Canaccord Genuity rates ((ALC)) as Buy (1) –

Alcidion Group’s 3Q25 update showed contracted revenue rose to $40.2m from $39.5m in February, prompting Canaccord Genuity to slightly upgrade revenue and earnings (EBITDA) estimates for FY25.

The broker notes the company’s fixed cost base has opened up the opportunity for operating leverage in FY26 and beyond.

EPS estimates largely unchanged. Buy. No change to 13c target.

This report was published on April 22, 2025.

Target price is $0.13 Current Price is $0.08 Difference: $0.046
If ALC meets the Canaccord Genuity target it will return approximately 55% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 14.00.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 84.00.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ALD    AMPOL LIMITED

Consumer Products & Services – Overnight Price: $22.42

Goldman Sachs rates ((ALD)) as Buy (1) –

Ampol’s 1Q25 update showed gross profit of US$50m at Lytton refinery fell short of Goldman Sachs’ US$59m forecast, largely due to Cyclone Alfred impact.

Convenience Retail and New Zealand earnings before interest and tax grew in 1Q and compares with the broker’s forecast for a -6% year-on-year and -13%  decline in 1H23 on the previous period. The broker is not adjusting forecasts due to volatile quarterly movements, but has flagged upside risks.

The F&I International business also performed well compared with the broker’s expectation.

No change to earnings (EBITDA) forecasts. Target rises to $30.80 from $30.60. Buy retained.

This report was published on April 17, 2025.

Target price is $30.80 Current Price is $22.42 Difference: $8.38
If ALD meets the Goldman Sachs target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $29.40, suggesting upside of 31.1%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 37.00 cents and EPS of 74.00 cents.
At the last closing share price the estimated dividend yield is 1.65%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 30.30.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 153.7, implying annual growth of 199.0%.
Current consensus DPS estimate is 96.7, implying a prospective dividend yield of 4.3%.
Current consensus EPS estimate suggests the PER is 14.6.

Forecast for FY26:

Goldman Sachs forecasts a full year FY26 dividend of 143.00 cents and EPS of 186.00 cents.
At the last closing share price the estimated dividend yield is 6.38%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.05.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 207.3, implying annual growth of 34.9%.
Current consensus DPS estimate is 159.7, implying a prospective dividend yield of 7.1%.
Current consensus EPS estimate suggests the PER is 10.8.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

BOQ    BANK OF QUEENSLAND LIMITED

Banks – Overnight Price: $7.39

Jarden rates ((BOQ)) as Neutral (3) –

Bank of Queensland’s 1H25 profit of $183m beat Jarden’s forecast of $164m due mainly to a $20m write-back of commercial lending and costs timing.

Net interest margin was flat at 1.57% but the broker expects this to rise to 1.68% in 2H due to a one-off benefit from the transition of owner-managed branches to corporate-owned and recent recycling of Vigrin Money mortgages. The forecast for FY25 is 1.64%.

The broker believes the bank is on a path to improving returns but is still forecasting a 6.4% return on equity in FY26 against the target of 8%.

FY25 EPS forecast lifted by 9.3% and FY26 by 2.7%, mainly on lower bad debt charge.

Neutral. Target rises to $6.70 from $6.50.

This report was published on April 16, 2025.

Target price is $6.70 Current Price is $7.39 Difference: minus $0.69 (current price is over target).
If BOQ meets the Jarden target it will return approximately minus 9% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $6.38, suggesting downside of -13.7%(ex-dividends)
The company’s fiscal year ends in August.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 36.00 cents and EPS of 53.10 cents.
At the last closing share price the estimated dividend yield is 4.87%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.92.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 54.7, implying annual growth of 26.1%.
Current consensus DPS estimate is 37.0, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 13.5.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 38.00 cents and EPS of 55.80 cents.
At the last closing share price the estimated dividend yield is 5.14%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.24.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 57.4, implying annual growth of 4.9%.
Current consensus DPS estimate is 39.2, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 12.9.

Market Sentiment: -0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CKF    COLLINS FOODS LIMITED

Food, Beverages & Tobacco – Overnight Price: $8.24

Canaccord Genuity rates ((CKF)) as Hold (3) –

Canaccord Genuity admires the strategic initiatives announced by Collins Foods under its new CEO, seeing them as offering higher medium-term growth optionality.

The decision to exit Taco Bell is wise, the broker notes, but without full details makes no change to forecasts for now. The German expansion and realignment of Netherlands operations would require higher capex and leave less free cash flow.

Minor revisions to FY2526 forecasts, with capex the biggest change in the medium-term forecasts.

Target unchanged at $8. Hold maintained, with stronger volume growth in Australia needed to see the broker become more constructive on the stock.

This report was published on April 23, 2025.

Target price is $8.00 Current Price is $8.24 Difference: minus $0.24 (current price is over target).
If CKF meets the Canaccord Genuity target it will return approximately minus 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $9.75, suggesting upside of 18.3%(ex-dividends)
The company’s fiscal year ends in April.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 22.00 cents and EPS of 37.60 cents.
At the last closing share price the estimated dividend yield is 2.67%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.91.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of -21.1%.
Current consensus DPS estimate is 22.4, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 21.7.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 25.50 cents and EPS of 45.80 cents.
At the last closing share price the estimated dividend yield is 3.09%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.99.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 51.9, implying annual growth of 36.9%.
Current consensus DPS estimate is 29.0, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 15.9.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Jarden rates ((CKF)) as Overweight (2) –

The main announcement in Collins Foods’ strategic update under new leadership was the focus on German growth with a plan to accelerate store roll outs. Jarden believes this will be value accretive.

The roll outs in Australia are expected to continue, but the broker sees risk for same-store sales growth in 2H as competition intensifies. The company is exiting the Taco Bell brand in FY26, and taking a partial impairment in the Netherlands due to underperformance.

The broker cut FY25-27 EPS forecasts,  but expects improvement from FY28, mainly on German acceleration.

Overweight. Target lifts to $9.95 from $9.40.

This report was published on April 16, 2025.

Target price is $9.95 Current Price is $8.24 Difference: $1.71
If CKF meets the Jarden target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $9.75, suggesting upside of 18.3%(ex-dividends)
The company’s fiscal year ends in April.

Forecast for FY25:

Jarden forecasts a full year FY25 EPS of 36.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.39.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of -21.1%.
Current consensus DPS estimate is 22.4, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 21.7.

Forecast for FY26:

Jarden forecasts a full year FY26 EPS of 51.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.06.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 51.9, implying annual growth of 36.9%.
Current consensus DPS estimate is 29.0, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 15.9.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CVV    CARAVEL MINERALS LIMITED

Copper – Overnight Price: $0.15

Canaccord Genuity rates ((CVV)) as Speculative Buy (1) –

Caravel Minerals’ definitive engineering study for the Caravel Copper Project in Western Australia showed it could use conventional primary crushing, grinding and flotation. 

Canaccord Genuity notes this could reduce capex, though it would likely be offset by cost inflation since the last capex estimate of $1.7bn was issued in April 2023.

The broker estimates lower opex is a possibility due to lower energy consumption. The details of recoveries were mixed but largely offsetting, with lower copper and molybdenum recoveries compensated by higher grades for gold and silver which were previously regarded as by-product.

Speculative Buy. Target unchanged at 60c.

This report was published on April 23, 2025.

Target price is $0.60 Current Price is $0.15 Difference: $0.445
If CVV meets the Canaccord Genuity target it will return approximately 287% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.00 cents.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 5.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 3.10.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

DHG    DOMAIN HOLDINGS AUSTRALIA LIMITED

Real Estate – Overnight Price: $4.16

Jarden rates ((DHG)) as Overweight (2) –

Jarden analysts concede their expectation for a 6% rise in the March quarter residential listing volumes was optimistic, as PropTrack data showed listings were largely flat. 

The broker cut forecasts for 2H25 residential volume growth for both REA Group ((REA)) and Domain Holdings Australia to -4.0% from -2.5%, respectively. The broker also revised pricing estimates for FY26, resulting in a modest earnings (EBITDA) downgrade of -2.0% for the company.

EPS forecasts for FY25 and FY26 trimmed by -2.5% and -4.0%, respectively.

Overweight. Target price $4.43, reflecting the value of CoStar’s offer. The broker’s standalone valuation for the company is $3.30.

This report was published on April 15, 2025.

Target price is $4.43 Current Price is $4.16 Difference: $0.27
If DHG meets the Jarden target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $3.38, suggesting downside of -18.9%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 6.00 cents and EPS of 8.70 cents.
At the last closing share price the estimated dividend yield is 1.44%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 47.82.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 9.1, implying annual growth of 35.4%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 45.7.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 6.50 cents and EPS of 10.00 cents.
At the last closing share price the estimated dividend yield is 1.56%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 41.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 10.6, implying annual growth of 16.5%.
Current consensus DPS estimate is 7.1, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 39.2.

Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

DYL    DEEP YELLOW LIMITED

Uranium – Overnight Price: $1.02

Canaccord Genuity rates ((DYL)) as Speculative Buy (1) –

There was no material new update in Deep Yellow’s 3Q25 report for Canaccord Genuity to have a re-look at its forecasts.

The company reported a cash balance of $227m, down -$9m from end-December.

Upcoming catalysts include results from pre-mining grade control drilling at Tumas Uranium project, Mulga Rock revised mineral resource estimate and potential for additional exploration at Tumas.

Speculative Buy. Target $1.61.

This report was published on April 22, 2025.

Target price is $1.61 Current Price is $1.02 Difference: $0.585
If DYL meets the Canaccord Genuity target it will return approximately 57% (excluding dividends, fees and charges).
Current consensus price target is $1.57, suggesting upside of 53.2%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 1.23 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 83.40.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -0.1, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.69 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 60.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -3.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

FEX    FENIX RESOURCES LIMITED

Iron Ore – Overnight Price: $0.29

Petra Capital rates ((FEX)) as Buy (1) –

Petra Capital highlights Fenix Resources’ iron ore shipment in 3Q25 was a record 704,000 wmt, putting it on track to lift the annual production rate to 4Mtpa in 2025. Shipments at both the Iron Ridge and Shine mines beat the broker’s forecast.

The company remains on track for first production at Beebyn-W11 in the September quarter, and the broker expects the 4Mtpa run-rate to be achieved in the December quarter.

The company isn’t sweetening its offer for CZR Resources ((CZR)), so it could lose on the acquisition opportunity against a counter-bid from Rio Tinto/Mitsui JV. The broker expects other opportunities to be investigated.

Buy. Target rises to 40c from 39c.

This report was published on April 23, 2025.

Target price is $0.40 Current Price is $0.29 Difference: $0.11
If FEX meets the Petra Capital target it will return approximately 38% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.15.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 1.40 cents and EPS of 5.00 cents.
At the last closing share price the estimated dividend yield is 4.83%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.80.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ILU    ILUKA RESOURCES LIMITED

Mineral Sands – Overnight Price: $3.82

Goldman Sachs rates ((ILU)) as Buy (1) –

Iluka Resources’ 1Q25 mineral sands revenue of $260m fell well short of Goldman Sachs’ forecast of $325m due to lower synthetic rutile sales and lower realised prices across all products.

The broker notes the outlook for zircon looks positive based on strong contracted volumes for 2Q and steady prices. The company maintained the guidance for FY25.

The broker cut FY25 EPS forecast by -32% and FY26 by -9% after lowering pricing, adjusting production estimates and increasing capitalised inventory.

Target price trimmed to $6.50 from $6.60. Buy retained.

This report was published on April 16, 2025.

Target price is $6.50 Current Price is $3.82 Difference: $2.68
If ILU meets the Goldman Sachs target it will return approximately 70% (excluding dividends, fees and charges).
Current consensus price target is $5.15, suggesting upside of 34.8%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 5.00 cents and EPS of 15.00 cents.
At the last closing share price the estimated dividend yield is 1.31%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.47.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 40.3, implying annual growth of -25.6%.
Current consensus DPS estimate is 7.6, implying a prospective dividend yield of 2.0%.
Current consensus EPS estimate suggests the PER is 9.5.

Forecast for FY26:

Goldman Sachs forecasts a full year FY26 dividend of 49.00 cents and EPS of 41.00 cents.
At the last closing share price the estimated dividend yield is 12.83%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.32.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 47.6, implying annual growth of 18.1%.
Current consensus DPS estimate is 9.8, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 8.0.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

KAR    KAROON ENERGY LIMITED

Crude Oil – Overnight Price: $1.39

Goldman Sachs rates ((KAR)) as Buy (1) –

The bigger news than Karoon Energy’s 1Q25 report was the announcement that it is progressing the Neon Oil Project into the Define phase over the next 12 months. The broker notes the update is a positive step in unlocking value from the company’s resource base.

The broker increased Neon’s risk weighting to 50% from 25% and considers it appropriate until the project moves further and funding arrangements are put in place.

In 1Q, production was 3% ahead of the broker’s forecast, but sales and revenue fell short by -6% on Bauna shipment timing.

Marginal revisions to earnings (EBITDA) forecasts. Target rises to $2.13 from $2.01 on Neon update. Buy retained.

This report was published on April 16, 2025.

Target price is $2.13 Current Price is $1.39 Difference: $0.74
If KAR meets the Goldman Sachs target it will return approximately 53% (excluding dividends, fees and charges).
Current consensus price target is $2.17, suggesting upside of 56.1%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 5.38 cents and EPS of 18.44 cents.
At the last closing share price the estimated dividend yield is 3.87%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.54.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 21.6, implying annual growth of N/A.
Current consensus DPS estimate is 4.6, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 6.4.

Forecast for FY26:

Goldman Sachs forecasts a full year FY26 dividend of 7.84 cents and EPS of 26.12 cents.
At the last closing share price the estimated dividend yield is 5.64%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.32.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 24.3, implying annual growth of 12.5%.
Current consensus DPS estimate is 6.7, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 5.7.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Jarden rates ((KAR)) as Overweight (2) –

Karoon Energy’s 1Q25 group production was 2% higher than Jarden’s forecast and sales revenue was in line, but the highlight was the resource upgrade at the 100%-owned Neon oil field.

The company will now progress Neon to the “Define” phase, prompting the broker to update its valuation to 37c unrisked from 12c, with 25% risked-weighted valuation.

Minor changes to forecasts. Overweight. Target rises to $1.60 from $1.53.

This report was published on April 16, 2025.

Target price is $1.60 Current Price is $1.39 Difference: $0.21
If KAR meets the Jarden target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $2.17, suggesting upside of 56.1%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 5.99 cents and EPS of 23.05 cents.
At the last closing share price the estimated dividend yield is 4.31%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.03.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 21.6, implying annual growth of N/A.
Current consensus DPS estimate is 4.6, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 6.4.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 4.76 cents and EPS of 18.59 cents.
At the last closing share price the estimated dividend yield is 3.43%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.48.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 24.3, implying annual growth of 12.5%.
Current consensus DPS estimate is 6.7, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 5.7.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

MYX    MAYNE PHARMA GROUP LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $7.03

Canaccord Genuity rates ((MYX)) as Hold (3) –

Mayne Pharma’s 3Q25 underlying earnings (EBITDA) missed Canaccord Genuity’s forecast by -$3.4m, though year-to-date performance was up year-on-year. The year-on-year performance matters for the Cosette Pharma acquisition offer because underlying earnings (EBITDA) below the -$10m delta versus FY24 could trigger a material adverse clause.

The broker believes there’s a high probability the acquisition will go through, unless 4Q performance is very weak. The company also guided to FY25 underlying earnings (EBITDA) of $47-51m, which fell short of the broker’s estimate but points to 105-123% improvement over FY24.

Hold. Target unchanged at $7.40.

This report was published on April 22, 2025.

Target price is $7.40 Current Price is $7.03 Difference: $0.37
If MYX meets the Canaccord Genuity target it will return approximately 5% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NAN    NANOSONICS LIMITED

Medical Equipment & Devices – Overnight Price: $4.59

Wilsons rates ((NAN)) as Overweight (1) –

Following a site tour of Nanosonics’ facilities to see the Coris system in operation, Wilsons believes the product could get 2-3 times higher average selling price than initially assumed.

The broker also thinks its assumption for the Quantum consumable pricing revenue is on the conservative side.

The analyst reiterated Coris would become earnings before interest and tax positive in a few years and the current share pricing only factors 50% of the value.

Overweight. Target unchanged at $6.

This report was published on April 23, 2025.

Target price is $6.00 Current Price is $4.59 Difference: $1.41
If NAN meets the Wilsons target it will return approximately 31% (excluding dividends, fees and charges).
Current consensus price target is $4.66, suggesting upside of 1.6%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 5.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 85.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 6.2, implying annual growth of 44.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 74.0.

Forecast for FY26:

Wilsons forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 97.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.4, implying annual growth of 19.4%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 62.0.

Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NEC    NINE ENTERTAINMENT CO. HOLDINGS LIMITED

Print, Radio & TV – Overnight Price: $1.39

Jarden rates ((NEC)) as Overweight (2) –

Jarden has updated forecasts for Nine Entertainment to capture revised forecasts for Domain Holdings Australia ((DHG)) which was on the back of a downgrade to residential listing volumes forecast for 2H25.

EPS forecast for FY25 trimmed by -0.6% and by -1.1% for FY26.

Overweight. Target unchanged at $1.85.

This report was published on April 15, 2025.

Target price is $1.85 Current Price is $1.39 Difference: $0.46
If NEC meets the Jarden target it will return approximately 33% (excluding dividends, fees and charges).
Current consensus price target is $1.82, suggesting upside of 30.7%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 5.70 cents and EPS of 8.10 cents.
At the last closing share price the estimated dividend yield is 4.10%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.16.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 9.7, implying annual growth of 41.2%.
Current consensus DPS estimate is 6.5, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 14.3.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 6.50 cents and EPS of 9.20 cents.
At the last closing share price the estimated dividend yield is 4.68%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.11.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.1, implying annual growth of 35.1%.
Current consensus DPS estimate is 9.5, implying a prospective dividend yield of 6.8%.
Current consensus EPS estimate suggests the PER is 10.6.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NWS    NEWS CORPORATION

Print, Radio & TV – Overnight Price: $48.38

Jarden rates ((NWS)) as Overweight (2) –

Ahead of News Corp’s 3Q25 result in May, Jarden expects adjusted net profit of US$73m vs consensus of US$83m.

The broker is already factoring in softer advertising revenues due to macroeconomic uncertainty and structural pressures, but will be looking for details around this. Other surprises could come from volumes at REA Group ((REA)) vs the broker’s expectation of flat 3Q and -8% quarter-on-quarter in Q4.

The analyst cut FY25 EPS forecast by -0.6% and lifted FY26 by 1.4% after changes to REA estimates and updating forex assumptions.

Overweight. Target price $53.

This report was published on April 15, 2025.

Target price is $53.00 Current Price is $48.38 Difference: $4.62
If NWS meets the Jarden target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $62.75, suggesting upside of 29.7%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 30.73 cents and EPS of 127.54 cents.
At the last closing share price the estimated dividend yield is 0.64%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 37.93.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 131.5, implying annual growth of N/A.
Current consensus DPS estimate is 39.1, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 36.8.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 30.73 cents and EPS of 139.83 cents.
At the last closing share price the estimated dividend yield is 0.64%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 34.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 159.7, implying annual growth of 21.4%.
Current consensus DPS estimate is 39.1, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 30.3.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

PRN    PERENTI LIMITED

Mining Sector Contracting – Overnight Price: $1.36

Canaccord Genuity rates ((PRN)) as Buy (1) –

Canaccord Genuity believes Perenti’s contract termination with MMG for the Khoemacau Copper Mine on June 30 is a negative, but partly offset by the fact the contract was underperforming and the outlook for the company remains upbeat.

The broker slightly downgraded earnings (EBITDA) forecast for FY26 while noting a large tender pipeline and the company’s investment in Botswana increases growth opportunities beyond FY26.

The boost to the balance sheet from the equipment sale to MMG supports ongoing capital management, the broker notes.

Buy. Target lifted to $1.48 from $1.35 on free cash flow profile and gold exposure.

This report was published on April 23, 2025.

Target price is $1.48 Current Price is $1.36 Difference: $0.12
If PRN meets the Canaccord Genuity target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $1.52, suggesting upside of 12.0%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 6.00 cents and EPS of 13.70 cents.
At the last closing share price the estimated dividend yield is 4.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.93.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 17.4, implying annual growth of 60.4%.
Current consensus DPS estimate is 6.4, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 7.8.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 6.50 cents and EPS of 17.10 cents.
At the last closing share price the estimated dividend yield is 4.78%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.95.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 18.7, implying annual growth of 7.5%.
Current consensus DPS estimate is 6.7, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 7.3.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

QBE    QBE INSURANCE GROUP LIMITED

Insurance – Overnight Price: $21.43

Goldman Sachs rates ((QBE)) as Buy (1) –

US-based Travelers reported 1Q25 results and Goldman Sachs reckons it has mostly positive implications for QBE Insurance.

Travelers’ 1Q25 underlying Business Interruptions combined operating ratio (COR) saw an improvement to 88.2% y/y from 89.2%.

Underlying Personal Insurance COR also declined to 80% on the previous period from 86% but reported COR was elevated on higher catastrophes. The broker believes this has greater implications for QBE’s non-core portfolio losses this year.

Buy. Target unchanged at $25.

This report was published on April 17, 2025.

Target price is $25.00 Current Price is $21.43 Difference: $3.57
If QBE meets the Goldman Sachs target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $23.35, suggesting upside of 9.0%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 89.10 cents and EPS of 175.48 cents.
At the last closing share price the estimated dividend yield is 4.16%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.21.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 182.7, implying annual growth of N/A.
Current consensus DPS estimate is 89.2, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 11.7.

Forecast for FY26:

Goldman Sachs forecasts a full year FY26 dividend of 97.70 cents and EPS of 197.45 cents.
At the last closing share price the estimated dividend yield is 4.56%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.85.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 198.1, implying annual growth of 8.4%.
Current consensus DPS estimate is 97.2, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 10.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

REA    REA GROUP LIMITED

Real Estate – Overnight Price: $239.93

Jarden rates ((REA)) as Underweight (4) –

Jarden analysts concede their expectation for a 6% rise in the March quarter residential listing volumes was optimistic, as PropTrack data showed listings were largely flat. 

The broker cut forecasts for 2H25 residential volume growth for both REA Group and Domain Holdings Australia ((DHG)) to -4.0% from -2.5%. The broker also revised pricing estimates for FY26, resulting in a modest 1% lift in earnings (EBITDA).

EPS forecasts for FY25 trimmed by -0.3% but lifted by 1.1% for FY26.

Underweight. Target unchanged at $210.

This report was published on April 15, 2025.

Target price is $210.00 Current Price is $239.93 Difference: minus $29.93 (current price is over target).
If REA meets the Jarden target it will return approximately minus 12% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $269.43, suggesting upside of 12.3%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 237.90 cents and EPS of 437.80 cents.
At the last closing share price the estimated dividend yield is 0.99%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 54.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 435.1, implying annual growth of 89.8%.
Current consensus DPS estimate is 237.0, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 55.1.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 281.10 cents and EPS of 516.70 cents.
At the last closing share price the estimated dividend yield is 1.17%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 46.44.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 520.1, implying annual growth of 19.5%.
Current consensus DPS estimate is 286.8, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 46.1.

Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

RIO    RIO TINTO LIMITED

Bulks – Overnight Price: $114.92

Goldman Sachs rates ((RIO)) as Buy (1) –

Rio Tinto’s 1Q25 Pilbara iron ore shipment was -4% lower than Goldman Sachs’ forecast due to extreme wet weather but copper production beat by 6% on better grades and plant uptime. Most other divisions were lower on the previous quarter.

The company guided FY25 Pilbara volume to the lower end of the 323-338Mt range, prompting the broker to cut its already low estimate to 324Mt (from 325Mt).

FY25-26 EBITDA forecasts were cut by -2% on slightly lower Pilbara shipments and slightly higher unit costs.

Buy. Target cut to $140.80 from $141.90.

This report was published on April 17, 2025.

Target price is $140.80 Current Price is $114.92 Difference: $25.88
If RIO meets the Goldman Sachs target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $121.75, suggesting upside of 5.9%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 553.17 cents and EPS of 937.31 cents.
At the last closing share price the estimated dividend yield is 4.81%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 1000.3, implying annual growth of N/A.
Current consensus DPS estimate is 617.2, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 11.5.

Forecast for FY26:

Goldman Sachs forecasts a full year FY26 dividend of 568.53 cents and EPS of 952.67 cents.
At the last closing share price the estimated dividend yield is 4.95%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.06.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 967.0, implying annual growth of -3.3%.
Current consensus DPS estimate is 595.9, implying a prospective dividend yield of 5.2%.
Current consensus EPS estimate suggests the PER is 11.9.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SEK    SEEK LIMITED

Jobs & Skilled Labour Services – Overnight Price: $21.03

Jarden rates ((SEK)) as Buy (1) –

Jarden notes its jobs tracker, including the Seek employment index, points to better-than-expected volumes in March and April. Based on this, the broker has revised higher forecasts for Australia/NZ volume growth for Seek for 2H25 to -8% year-on-year from -10.5%. 

However, for Asia, the broker has cut the forecast for FY26 to a -5% annual fall in paid listing volumes versus the previous estimate of a 10% rise. This is due to a combination of macroeconomic uncertainty and “freemium” in certain Asian markets.

EPS forecast for FY25 lifted by 2% but lowered by -8% for FY26.

Buy. Target cut to $27.50 from $28.00.

This report was published on April 15, 2025.

Target price is $27.50 Current Price is $21.03 Difference: $6.47
If SEK meets the Jarden target it will return approximately 31% (excluding dividends, fees and charges).
Current consensus price target is $28.01, suggesting upside of 33.2%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 41.10 cents and EPS of 43.00 cents.
At the last closing share price the estimated dividend yield is 1.95%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 48.91.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 41.8, implying annual growth of N/A.
Current consensus DPS estimate is 40.3, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 50.3.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 42.80 cents and EPS of 53.50 cents.
At the last closing share price the estimated dividend yield is 2.04%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 39.31.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 60.5, implying annual growth of 44.7%.
Current consensus DPS estimate is 49.5, implying a prospective dividend yield of 2.4%.
Current consensus EPS estimate suggests the PER is 34.8.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SHV    SELECT HARVESTS LIMITED

Agriculture – Overnight Price: $4.98

Wilsons rates ((SHV)) as Market Weight (3) –

Select Harvests lowered FY25 production guidance to 24.0-26.5kt from 27.5-29.0kt, but raised the almond price forecast to $10.35/kg from $9.20/kg.

Wilsons cut FY25 almond production forecast by -11% to align with the midpoint of the updated guidance. The broker’s new price forecast is, however, higher than the guidance at $10.80/kg based on its view that tight global supply and tariff impact would provide upside.

The broker expects current price momentum to continue into FY26, before some pullback in FY27.

Market Weight. Target lifted to $4.73 from $4.64.

This report was published on April 22, 2025.

Target price is $4.73 Current Price is $4.98 Difference: minus $0.25 (current price is over target).
If SHV meets the Wilsons target it will return approximately minus 5% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $5.60, suggesting upside of 12.4%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 8.90 cents and EPS of 27.10 cents.
At the last closing share price the estimated dividend yield is 1.79%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.38.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 26.2, implying annual growth of 2012.9%.
Current consensus DPS estimate is 1.3, implying a prospective dividend yield of 0.3%.
Current consensus EPS estimate suggests the PER is 19.0.

Forecast for FY26:

Wilsons forecasts a full year FY26 dividend of 32.20 cents and EPS of 58.60 cents.
At the last closing share price the estimated dividend yield is 6.47%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.50.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of 44.7%.
Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 13.1.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

STN    SATURN METALS LIMITED

Gold & Silver – Overnight Price: $0.33

Petra Capital rates ((STN)) as Buy (1) –

Latest drilling results at Saturn Metals’ Apollo Hill Gold Project revealed thick and high-grade intercepts, raising the potential for a further upgrade in the current 2.03Moz resource, Petra Capital highlights.

The updated resource is expected in the September quarter, and a pre-feasibility study is targeted for the December quarter.

Buy. Target lifted to $1.17 from $0.98 on upwardly revised gold price, partly offset by dilution from the capital raise in March.

This report was published on April 24, 2025.

Target price is $1.17 Current Price is $0.33 Difference: $0.845
If STN meets the Petra Capital target it will return approximately 260% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 36.11.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 81.25.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

THL    TOURISM HOLDINGS LIMITED

Travel, Leisure & Tourism – Overnight Price: $1.35

Wilsons rates ((THL)) as Market Weight (3) –

A weakening in the operating environment due to global uncertainty and lower consumer confidence has hurt Tourism Holdings Rentals’ business. This has prompted the company to guide to FY25 net profit significantly lower than the consensus of NZ$45.2m.

Wilsons’ already had a cautious view on near-term prospects and net profit forecast of NZ$44.1m, but downgraded it further by -25% on cut to North American rental estimates and sales, and margins all over.

The broker highlights the company can manage gearing by cutting capex in FY26, and has headroom to borrow if required.

Market Weight. Target unchanged at $1.25.

This report was published on April 22, 2025.

Target price is $1.25 Current Price is $1.35 Difference: minus $0.1 (current price is over target).
If THL meets the Wilsons target it will return approximately minus 7% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $1.73, suggesting upside of 28.1%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 4.01 cents and EPS of 13.67 cents.
At the last closing share price the estimated dividend yield is 2.97%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.88.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 18.5, implying annual growth of N/A.
Current consensus DPS estimate is 7.1, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 7.3.

Forecast for FY26:

Wilsons forecasts a full year FY26 dividend of 8.66 cents and EPS of 16.31 cents.
At the last closing share price the estimated dividend yield is 6.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.28.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 24.8, implying annual growth of 34.1%.
Current consensus DPS estimate is 9.8, implying a prospective dividend yield of 7.3%.
Current consensus EPS estimate suggests the PER is 5.4.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

TLX    TELIX PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $28.56

Wilsons rates ((TLX)) as Overweight (1) –

Telix Pharmaceuticals’ 1Q25 revenue of US$186m beat Wilsons’ forecast by 5% due to stronger-than-expected revenue from RLS radiopharmacies that launched in January.

The broker’s forecasts are under review due to stronger RLS, but changes are not expected to be material. 

The company has moved to USD-reporting currency from January, and the broker expects historical USD-denominated results to be released shortly. Forecasts will be updated in USD when that happens.

Overweight. Target unchanged at $35.

This report was published on April 22, 2025.

Target price is $35.00 Current Price is $28.56 Difference: $6.44
If TLX meets the Wilsons target it will return approximately 23% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 31.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 91.54.

Forecast for FY26:

Wilsons forecasts a full year FY26 dividend of 0.00 cents and EPS of 58.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 48.57.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Click to view our Glossary of Financial Terms